Sandu Pharmaceuticals Ltd

AI
Sandu Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents
AI

Sandu Pharmaceuticals Ltd

₹ 37.0 1.90%
14 Aug - close price
sandu.in BSE: 524703
About

Incorporated in 1985, Sandu Pharmaceuticals
Ltd is a manufacturer of Ayurvedic Medicines.[1]

Key Points

Business Overview:[1]
SPL is engaged in the business of manufacturing and trading of Ayurveda based medicines under the brand name SANDU

Website BSE
  • Market Cap ₹ 35.7 Cr.
  • Current Price ₹ 37.0
  • High / Low ₹ 51.0 / 30.0
  • Stock P/E 23.0
  • Book Value ₹ 43.5
  • Dividend Yield 2.71 %
  • ROCE 5.47 %
  • ROE 3.75 %
  • Face Value ₹ 10.0
Edit ratios
Unsung hero
Ligin Bomjen
In 1943, the British had banned the salt trade. Ligin and his friends smuggled salt to their village. He also served as a porter during World War II.
Unsung hero
Accamma Cherian
She left teaching to join the freedom struggle and led a vast peaceful rally when Travancore's leaders were arrested. Gandhi called her the Jhansi Rani of Travancore.

Pros

  • Company is almost debt free.
  • Stock is trading at 0.85 times its book value
  • Company has been maintaining a healthy dividend payout of 34.3%

Cons

  • Promoter holding is low: 37.8%
  • Company has a low return on equity of 3.80% over last 3 years.
  • Promoter holding has decreased over last 3 years: -14.6%

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
11.42 16.23 16.76 17.09 15.26 17.66 16.61 17.43 15.60 17.05 17.70 18.37 14.07
10.85 15.91 15.90 16.27 14.77 17.31 15.79 16.92 14.99 16.64 16.79 17.37 13.62
Operating Profit 0.57 0.32 0.86 0.82 0.49 0.35 0.82 0.51 0.61 0.41 0.91 1.00 0.45
OPM % 4.99% 1.97% 5.13% 4.80% 3.21% 1.98% 4.94% 2.93% 3.91% 2.40% 5.14% 5.44% 3.20%
0.03 0.09 0.17 0.03 0.04 0.00 0.09 0.03 0.31 0.04 0.03 0.02 0.07
Interest 0.02 0.02 0.02 0.02 0.02 0.02 0.01 0.02 0.01 0.02 0.03 0.03 0.03
Depreciation 0.13 0.13 0.13 0.13 0.13 0.12 0.13 0.14 0.19 0.16 0.17 0.19 0.15
Profit before tax 0.45 0.26 0.88 0.70 0.38 0.21 0.77 0.38 0.72 0.27 0.74 0.80 0.34
Tax % 40.00% 34.62% 31.82% 30.00% 26.32% 47.62% 27.27% 44.74% 16.67% 40.74% 32.43% 30.00% 2.94%
0.27 0.17 0.60 0.48 0.27 0.11 0.55 0.21 0.59 0.17 0.50 0.56 0.33
EPS in Rs 0.31 0.19 0.62 0.50 0.28 0.11 0.57 0.22 0.61 0.18 0.52 0.58 0.34
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
65.50 65.35 67.28 67.19
62.62 62.87 64.98 64.43
Operating Profit 2.88 2.48 2.30 2.76
OPM % 4.40% 3.79% 3.42% 4.11%
0.08 0.33 0.42 0.17
Interest 0.11 0.08 0.06 0.10
Depreciation 0.53 0.52 0.58 0.67
Profit before tax 2.32 2.21 2.08 2.16
Tax % 31.47% 31.22% 29.33% 28.24%
1.59 1.52 1.46 1.55
EPS in Rs 1.80 1.57 1.51 1.60
Dividend Payout % 41.56% 0.00% 52.93% 49.86%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 1%
TTM: 0%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: -1%
TTM: 6%
Stock Price CAGR
10 Years: 2%
5 Years: -8%
3 Years: -14%
1 Year: -24%
Return on Equity
10 Years: %
5 Years: %
3 Years: 4%
Last Year: 4%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 8.81 9.66 9.66 9.66
Reserves 27.66 29.58 30.93 32.36
0.00 0.00 0.00 0.00
12.81 14.93 11.82 13.71
Total Liabilities 49.28 54.17 52.41 55.73
16.00 16.62 17.88 18.15
CWIP 0.48 0.42 0.00 0.00
Investments 9.11 9.65 10.42 11.22
23.69 27.48 24.11 26.36
Total Assets 49.28 54.17 52.41 55.73

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
0.95 0.22 0.76 0.95
-5.47 0.54 -1.31 -0.19
0.93 0.58 -0.72 -0.46
Net Cash Flow -3.59 1.34 -1.27 0.30
Free Cash Flow 0.11 -0.85 -0.67 0.01
CFO/OP 64% 37% 55% 55%

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 22.23 26.75 26.42 25.86
Inventory Days 115.06 167.70 137.28 160.90
Days Payable 69.63 98.30 47.07 51.05
Cash Conversion Cycle 67.67 96.15 116.63 135.70
Working Capital Days 42.41 52.33 56.75 62.80
ROCE % 6.05% 5.36% 5.47%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Diesel consumption
litres ・Standalone data

Log in to view insights

Please log in to see hidden values.

Login
Electricity purchased
units ・Standalone data
Furnace oil/LSHS consumption
litres ・Standalone data
Number of permanent employees
employees ・Standalone data
Number of product types
products ・Standalone data

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
42.91% 42.91% 42.91% 42.91% 42.91% 42.91% 42.91% 42.91% 42.91% 37.79% 37.79% 37.79%
0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01% 0.01%
57.10% 57.10% 57.09% 57.09% 57.09% 57.09% 57.09% 57.08% 57.09% 62.19% 62.20% 62.20%
No. of Shareholders 10,10310,02110,00110,01210,24610,33310,28710,22610,28410,28410,29810,268

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings